Unlocking capital markets for the benefit of small- and mid-cap biopharmaceutical companies in the European Union
Thursday, November 19, 2026
Invest Europe · Brussels, Belgium
This external event focuses on the financial challenges faced by small and mid-cap biopharmaceutical companies in the EU and aims to provide solutions for unlocking capital markets to support their growth.